

IP08: Imaging/Uroradiology I
Friday, May 15, 2026 9:30 AM to 11:30 AM · 2 hr. (America/New_York)
146A
Poster and Podium Sessions
Imaging/Radiology
Friday, May 15
IP08-01: Retrospective Analysis of MRI and Intraoperative Correlation in the Localisation of Undescended Testes in Indian Population
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-02: Is Peri-Renal Fat Thickness of the Contralateral Kidney as Measured on Pre-Operative Imaging Associated With Progression to Chronic Kidney Disease After Radical Nephrectomy?
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-03: Membranous Urethral Length as a Predictor for Urinary Incontinence After Holmium Enucleation of the Prostate for Benign Prostatic Hyperplasia
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-04: Assessment of Urinary Turbulence in the Renal Pelvis Using Cine MR Urography with MSDE Preparation
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-05: Ureteral Wall thickness in Predicting need for Surgical Intervention in Ureteric Calculi =7 mm: Single Centre Retrospective Analysis
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-06: Redefining Radiation-Free Surgery: Outcomes of Zero-Fluoro PCNL at a High-Volume Endourology Center
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
Mohamad Watfa · Cleveland Clinic
IP08-07: Comparison of the CHOKAI, STONE, and New STONE Scores for Predicting Ureteral Stones: Evidence from a Multicenter Prospective Cohort
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-08: BMI-Stratified CT Dosing Protocol for Post-PCNL Imaging: Minimizing Radiation While Maintaining Diagnostic Accuracy
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-09: Restoring Bladder Control via Repetitive Transcranial Magnetic Stimulation of the Supplementary Motor Area and Dorsolateral Prefrontal Cortex in Idiopathic Overactive Bladder
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-10: AI-Assisted Cystoscopic Diagnosis for CIS and IC/HLD: Standardizing Visual Interpretation Across Malignant and Inflammatory Lesions
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-11: PLDAM: A Multimodal and Interpretable AI Model for Accurate Diagnosis and Risk Stratification of Pelvic Lipomatosis from CT and MRI
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-14: Dynamic MRI assessment of urethral stricture: a novel approach to noninvasive assessment of lower urinary tract biomechanics
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-13: Does the Presence of Balloon “Waisting” During Paclitaxel Drug-Coated Balloon Dilation Affect Success Rates?
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-15: Photoacoustic imaging for assessment of collagen remodeling and fibrosis in a partial bladder outlet obstruction rat model
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-16: DETRUSOR OVERACTIVITY EFFECTS ON BLADDER WALL MICROMOTION: A NON-INVASIVE ULTRASOUND AND URODYNAMICS STUDY
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-17: CHARACTERIZATION OF NORMAL BLADDER PARAMETERS USING 3D MAGNETIC RESONANCE FINGERPRINTING
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-18: High-Frequency Quantitative Micro-Ultrasound for Noninvasive Characterization of Renal Cancer Subtypes
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-19: Predicting Clear Cell Subtype for Kidney Tumors From Cross-Sectional Imaging Using Artificial Intelligence
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-20: Evaluation of Renal Imaging in patients with Birt-Hogg-Dubé Syndrome
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-21: Prognostic Impact of Sarcopenic Obesity and Systemic Inflammation in Non-Metastatic Renal Cell Carcinoma and Renal Oncocytoma.
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-22: Radiographic Response to Neoadjuvant Therapy for Renal Cell Carcinoma Does Not Correlate to Pathologic Response Using Immune-related Residual Viable Tumor (irRVT)
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-23: Radio-pathomic features associated with response to neoadjuvant cabozantinib in locally advanced renal cell carcinoma
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-24: Defining Use Cases for Girentuximab PET/CT in Urologic Oncology: Insights from an SUO Member Survey
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-25: Sub-5-minute Denoised PET Imaging of Indeterminate Renal Masses Using 89Zr-DFO-Girentuximab: A Feasibility Study
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-26: bp-VI-RADS Combined with Normalized ADC Enhances Diagnostic Efficacy for Muscle-Invasive Bladder Cancer
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-27: Clinical utility of ureteral optical coherence tomography for T staging of ureteral cancer: Toward optimal kidney-sparing strategy
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-28: Incidental Lung Nodules on PSMA PET and Opportunities for Early Lung Cancer Detection
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-29: Quantifying carbon and energy savings between prostate MRI protocols
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A
IP08-30: Evaluating the Positive Predictive Value of PSMA PET Following Primary Radiation Therapy in Suspected Recurrent Prostate Cancer
Friday, May 15, 2026 9:30 AM to 11:30 AM
146A

